SOURCE: SNN Incorporated

SNN Incorporated

October 19, 2015 08:30 ET

StockNewsNow.com Publishes New SNNLive Video Interview With Cynata Therapeutics Ltd.

LOS ANGELES, CA--(Marketwired - October 19, 2015) - StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Dr. Ross Macdonald, Managing Director and CEO of Cynata Therapeutics Ltd. (ASX: CYP), is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™, (see here: www.Cynata.com). The video interview was recorded at the SeeThruEquity Fall MicroCap Investor Conference 2015 in New York City, NY.

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:

Cynata Therapeutics Ltd. - Australian Stem Cell and Regenerative Medicine Company Developing Therapeutic Stem Cell Platform Technology

You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE, and STOCKTWITS

Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer

About Cynata Therapeutics Ltd.

Cynata Therapeutics Ltd (ASX: CYP) is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™, originating from the University of Wisconsin-Madison, a world leader in stem cell research. The proprietary Cymerus™ technology addresses a critical shortcoming in existing methods of production of mesenchymal stem cells (MSCs) for therapeutic use, which is the ability to achieve economic manufacture at commercial scale. Cymerus™ does so through the production of a particular type of MSC precursor, called a mesenchymoangioblast (MCA). The Cymerus™ MCA platform provides a source of MSCs that is independent of donor limitations and provides a potential "off-the-shelf" stem cell platform for therapeutic product use, with a pharmaceutical business model and economies of scale. This has the potential to create a new standard in the emergent arena of stem cell therapeutics and provides both a unique differentiator and an important competitive position.

Company description and for more information: www.Cynata.com

About StockNewsNow.com

StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature user-generated video, SNN-produced video like SNNLive CEO video interviews, as well as research reports, radio interviews, PowerPoint presentations, articles, and their latest news and headlines. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for -- all here on StockNewsNow.com.

Embedded Video Available: https://www.youtube.com/watch?v=KmDp5h6PZAI

Contact Information